CAB Spotlight - Vijaya Jori | Johns Hopkins University Baltimore-India Clinical Trials Unit

CAB Spotlight - Vijaya Jori

Date: 04/01/2022

Community Advisory Boards are key members of research programs. The ACTG Newsletter features Vijaya Jori of the JHU-BJGMC CAB!

A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...